Selective activation of GPR120 or free fatty acid receptor 4 (FFAR4) has therapeutic potential for the treatment of many diseases, including type 2 diabetes mellitus, osteoporosis, inflammation, and obesity41–43. The gene discussed is FFAR4; the disease is type 2 diabetes mellitus.